Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Per Engström

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Medical Physics|July 11, 2003
MAGIC-type polymer gel for three-dimensional dosimetry: intensity-modulated radiation therapy verificationHelen Gustavsson, Anna Karlsson, Sven A J Bäck, et al.
Clinical and Translational Radiation Oncology|June 12, 2026
Daily adaptive radiotherapy in head and neck squamous cell carcinoma can negatively impact organ at risk dosimetryHedda Enocson, André Haraldsson, Per Engström, et al.
Acta Oncologica (Stockholm, Sweden)|April 26, 2012
Introducing multiple treatment plan-based comparison to investigate the performance of gantry angle optimisation (GAO) in IMRT for head and neck cancerMaria Thor, Hunor Benedek, Tommy Knöös, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 5, 2002
Acceptance tests and quality control (QC) procedures for the clinical implementation of intensity modulated radiotherapy (IMRT) using inverse planning and the sliding window technique: experience from five radiotherapy departmentsAnn Van Esch, Jörg Bohsung, Pekka Sorvari, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 14, 2020
ARTSCAN III: A Randomized Phase III Study Comparing Chemoradiotherapy With Cisplatin Versus Cetuximab in Patients With Locoregionally Advanced Head and Neck Squamous Cell CancerMaria Gebre-Medhin, Eva Brun, Per Engström, et al.
International Journal of Radiation Oncology, Biology, Physics|June 21, 2025
Chemoradiation therapy With Cisplatin Versus Cetuximab in Patients With Locoregionally Advanced Head and Neck Squamous Cell Cancer-Mature Results of the ARTSCAN III TrialMaria Gebre-Medhin, Gabriel Adrian, Per Engström, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Medical Physics|July 11, 2003
MAGIC-type polymer gel for three-dimensional dosimetry: intensity-modulated radiation therapy verificationHelen Gustavsson, Anna Karlsson, Sven A J Bäck, et al.
Clinical and Translational Radiation Oncology|June 12, 2026
Daily adaptive radiotherapy in head and neck squamous cell carcinoma can negatively impact organ at risk dosimetryHedda Enocson, André Haraldsson, Per Engström, et al.
Acta Oncologica (Stockholm, Sweden)|April 26, 2012
Introducing multiple treatment plan-based comparison to investigate the performance of gantry angle optimisation (GAO) in IMRT for head and neck cancerMaria Thor, Hunor Benedek, Tommy Knöös, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 5, 2002
Acceptance tests and quality control (QC) procedures for the clinical implementation of intensity modulated radiotherapy (IMRT) using inverse planning and the sliding window technique: experience from five radiotherapy departmentsAnn Van Esch, Jörg Bohsung, Pekka Sorvari, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 14, 2020
ARTSCAN III: A Randomized Phase III Study Comparing Chemoradiotherapy With Cisplatin Versus Cetuximab in Patients With Locoregionally Advanced Head and Neck Squamous Cell CancerMaria Gebre-Medhin, Eva Brun, Per Engström, et al.
International Journal of Radiation Oncology, Biology, Physics|June 21, 2025
Chemoradiation therapy With Cisplatin Versus Cetuximab in Patients With Locoregionally Advanced Head and Neck Squamous Cell Cancer-Mature Results of the ARTSCAN III TrialMaria Gebre-Medhin, Gabriel Adrian, Per Engström, et al.
Pageof 2